Top

Published in:

Open Access 01-06-2018 | Original Article

The determinants of reduced dietary intake in hospitalised colorectal cancer patients

Authors: Anne van der Werf, Katherine Arthey, Michael Hiesmayr, Isabella Sulz, Karin Schindler, Alessandro Laviano, Jacqueline Langius, Marian de van der Schueren

Published in: Supportive Care in Cancer | Issue 6/2018

Abstract

Purpose

Patients with colorectal cancer (CRC) often experience malnutrition and weight loss, largely resulting from reduced dietary intake. The aim of this study was to identify determinants of reduced dietary intake in order to facilitate early recognition of malnutrition and optimise nutritional treatment.

Methods

Data from nutritionDay, an international 1-day survey investigating patient, disease and food profiles, were used. To identify determinants of dietary intake, defined as normal vs. reduced in the last week, univariate and multivariate logistic regressions were performed.

Results

Of 1131 hospitalised CRC patients, 54% reported reduced dietary intake. Patient- and disease-related characteristics significantly associated with reduced dietary intake were female gender (odds ratio (OR) 1.38), cancer stage III (OR 1.52) or IV (OR 1.70) vs. I, performance status 2 (OR 1.56), 3 (OR 2.37) or 4 (OR 4.15) vs. 0, duration since hospital admission of ≥ 4 days (OR 4–7 days, 1.91; 8–21 days, 1.97; > 21 days, 1.92) vs. < 4 days, and unintentional weight loss (OR 2.56). Additionally, higher symptom scores of pain, weakness, depression, tiredness and lack of appetite were associated with reduced intake.

Conclusions

Patient- and disease-related determinants for reduced dietary intake were being female, higher cancer stage, worse performance status, duration since hospital admission ≥ 4 days and unintentional weight loss. Furthermore, multiple symptoms were associated with a reduced dietary intake. Future trials should assess whether early recognition of patients at risk of malnutrition and the combination of treating symptoms and dietary advice result in improved intake and treatment-related outcomes.

Aaldriks AA, van der Geest LG, Giltay EJ, le Cessie S, Portielje JE, Tanis BC, Nortier JW, Maartense E (2013) Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol 4(3):218–226. https://doi.org/10.1016/j.jgo.2013.04.001 CrossRefPubMed

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hutterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Muhlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11–48. https://doi.org/10.1016/j.clnu.2016.07.015 CrossRefPubMed

Barret M, Malka D, Aparicio T, Dalban C, Locher C, Sabate JM, Louafi S, Mansourbakht T, Bonnetain F, Attar A, Taieb J (2011) Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study. Oncology 81(5-6):395–402. https://doi.org/10.1159/000335478 CrossRefPubMed

Bauer J, Capra S, Ferguson M (2002) Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56(8):779–785. https://doi.org/10.1038/sj.ejcn.1601412 CrossRefPubMed

Bernstein IL (1985) Learned food aversions in the progression of cancer and its treatment. Ann N Y Acad Sci 443(1 Experimental):365–380. https://doi.org/10.1111/j.1749-6632.1985.tb27086.x CrossRefPubMed

Bye A, Jordhoy MS, Skjegstad G, Ledsaak O, Iversen PO, Hjermstad MJ (2013) Symptoms in advanced pancreatic cancer are of importance for energy intake. Support Care Cancer 21(1):219–227. https://doi.org/10.1007/s00520-012-1514-8 CrossRefPubMed

Capra S, Ferguson M, Ried K (2001) Cancer: impact of nutrition intervention outcome—nutrition issues for patients. Nutrition 17(9):769–772. https://doi.org/10.1016/S0899-9007(01)00632-3 CrossRefPubMed

Cheng KK (2007) Oral mucositis, dysfunction, and distress in patients undergoing cancer therapy. J Clin Nurs 16(11):2114–2121. https://doi.org/10.1111/j.1365-2702.2006.01618.x CrossRefPubMed

Daudt HM, Cosby C, Dennis DL, Payeur N, Nurullah R (2012) Nutritional and psychosocial status of colorectal cancer patients referred to an outpatient oncology clinic. Support Care Cancer 20(7):1417–1423. https://doi.org/10.1007/s00520-011-1224-7 CrossRefPubMed

10.

Davis MP, Walsh D, Lagman R, Yavuzsen T (2006) Early satiety in cancer patients: a common and important but underrecognized symptom. Support Care Cancer 14(7):693–698. https://doi.org/10.1007/s00520-005-0015-4 CrossRefPubMed

11.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/ijc.29210 CrossRef

12.

Grant M, Kravits K (2000) Symptoms and their impact on nutrition. Semin Oncol Nurs 16(2):113–121. https://doi.org/10.1053/on.2000.5738 CrossRefPubMed

13.

Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF (2005) Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr 59(1):35–40. https://doi.org/10.1038/sj.ejcn.1602029 CrossRefPubMed

14.

Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG, Lammersfeld CA (2006) Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol 59(7):704–709. https://doi.org/10.1016/j.jclinepi.2005.08.020 CrossRefPubMed

15.

Hebuterne X, Lemarie E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F (2014) Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J Parenter Enteral Nutr 38(2):196–204. https://doi.org/10.1177/0148607113502674 CrossRefPubMed

16.

Hiesmayr M, Schindler K, Pernicka E, Schuh C, Schoeniger-Hekele A, Bauer P, Laviano A, Lovell AD, Mouhieddine M, Schuetz T, Schneider SM, Singer P, Pichard C, Howard P, Jonkers C, Grecu I, Ljungqvist O, Team NA (2009) Decreased food intake is a risk factor for mortality in hospitalised patients: the NutritionDay survey 2006. Clin Nutr 28(5):484–491. https://doi.org/10.1016/j.clnu.2009.05.013 CrossRefPubMed

17.

Hu WH, Cajas-Monson LC, Eisenstein S, Parry L, Cosman B, Ramamoorthy S (2015) Preoperative malnutrition assessments as predictors of postoperative mortality and morbidity in colorectal cancer: an analysis of ACS-NSQIP. Nutr J 14:91CrossRef

18.

Kim JY, Wie GA, Cho YA, Kim SY, Kim SM, Son KH, Park SJ, Nam BH, Joung H (2011) Development and validation of a nutrition screening tool for hospitalized cancer patients. Clin Nutr 30(6):724–729. https://doi.org/10.1016/j.clnu.2011.06.001 CrossRefPubMed

19.

Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Grp EW (2003) Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 22(3):321–336. https://doi.org/10.1016/S0261-5614(02)00214-5 CrossRefPubMed

20.

Kwag SJ, Kim JG, Kang WK, Lee JK, ST O (2014) The nutritional risk is an independent factor for postoperative morbidity in surgery for colorectal cancer. Ann Surg Treat Res 86(4):206–211. https://doi.org/10.4174/astr.2014.86.4.206 CrossRefPubMedPubMedCentral

21.

Mosel DD, Bauer RL, Lynch DP, Hwang ST (2011) Oral complications in the treatment of cancer patients. Oral Dis 17(6):550–559. https://doi.org/10.1111/j.1601-0825.2011.01788.x CrossRefPubMed

22.

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, Mcfadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern-Cooperative-Oncology-Group. Am J Clin Oncol Canc 5:649–655CrossRef

23.

Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2003) Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol (R Coll Radiol) 15(8):443–450. https://doi.org/10.1016/S0936-6555(03)00155-9 CrossRef

24.

Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2005) Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23(7):1431–1438. https://doi.org/10.1200/JCO.2005.02.054 CrossRefPubMed

25.

Read JA, Choy ST, Beale PJ, Clarke SJ (2006) Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer 55(1):78–85. https://doi.org/10.1207/s15327914nc5501_10 CrossRefPubMed

26.

Schwegler I, von Holzen A, Gutzwiller JP, Schlumpf R, Muhlebach S, Stanga Z (2010) Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg 97(1):92–97. https://doi.org/10.1002/bjs.6805 CrossRefPubMed

27.

Solheim TS, Blum D, Fayers PM, Hjermstad MJ, Stene GB, Strasser F, Kaasa S (2014) Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: three peas in a pod?—analysis from a multicenter cross sectional study. Acta Oncol 53(4):539–546. https://doi.org/10.3109/0284186X.2013.823239 CrossRefPubMed

28.

Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, Prado CM, Birdsell L, Falkmer U (2013) Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results. Clin Nutr 32(1):65–72. https://doi.org/10.1016/j.clnu.2012.05.009 CrossRefPubMed

29.

Tokunaga R, Sakamoto Y, Nakagawa S, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Baba H (2015) Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection. Dis Colon Rectum 58(11):1048–1057. https://doi.org/10.1097/DCR.0000000000000458 CrossRefPubMed

30.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRef

31.

Tu MY, Chien TW, Chou MT (2012) Using a nutritional screening tool to evaluate the nutritional status of patients with colorectal cancer. Nutr Cancer 64:323–330CrossRef

32.

von Meyenfeldt M (2005) Cancer-associated malnutrition: an introduction. Eur J Oncol Nurs 9(Suppl 2):S35–S38. https://doi.org/10.1016/j.ejon.2005.09.001 CrossRef

33.

Wie GA, Cho YA, Kim SY, Kim SM, Bae JM, Joung H (2010) Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the National Cancer Center in Korea. Nutrition 26(3):263–268. https://doi.org/10.1016/j.nut.2009.04.013 CrossRefPubMed

34.

Wu BW, Yin T, Cao WX, ZD G, Wang XJ, Yan M, Liu BY (2009) Clinical application of subjective global assessment in Chinese patients with gastrointestinal cancer. World J Gastroenterol 15:3542–3549CrossRef

Title: The determinants of reduced dietary intake in hospitalised colorectal cancer patients
Authors: Anne van der Werf
Katherine Arthey
Michael Hiesmayr
Isabella Sulz
Karin Schindler
Alessandro Laviano
Jacqueline Langius
Marian de van der Schueren
Publication date: 01-06-2018
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 6/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-018-4044-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2018

Administrating docetaxel, doxorubicin, and cyclophosphamide as a neoadjuvant treatment may decrease lymphedema risk in breast cancer patients

Parent perspectives and preferences for strategies regarding nonsedated MRI scans in a pediatric oncology population

Characteristics and care pathways of advanced cancer patients in a palliative-supportive care unit and an oncological ward

Convergent priorities and tensions: a qualitative study of the integration of complementary and alternative therapies with conventional cancer treatment

A hospital and home-based exercise program to address functional decline in people following allogeneic stem cell transplantation

Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey

Keynote webinar | Spotlight on antibody–drug conjugates in cancer